GLP1 & CKD

In this episode of the Kidney Commute podcast, panelists delve into the role of glucagon-like peptide-1 (GLP-1) receptor agonists in chronic kidney disease. The discussion explores the mechanisms of GLP-1 receptor agonists, their benefits in managing both kidney disease and related comorbidities like diabetes and cardiovascular disease, and the latest evidence supporting their use. Panelists also address practical challenges faced by both patients and providers.